Europe (WHO region) vs Turkmenistan: Previously treated cases tested for RR-/MDR-TB
Europe (WHO region)
90.0%
in 2024
Turkmenistan
100.0%
in 2022
Europe (WHO region) rank
2nd
Turkmenistan rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Europe (WHO region)
- Turkmenistan
How they compare
Turkmenistan currently reports 100.0% against 90.0% in Europe (WHO region), a difference of 10.0%.
That makes Turkmenistan's figure about 1.1 times Europe (WHO region)'s.
The two have swapped places 2 times across 6 shared years of data; in 2006 it was Turkmenistan ahead.
Europe (WHO region) ranks 2nd and Turkmenistan ranks 1st of 11 groups.
Turkmenistan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Europe (WHO region) | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20.0% | 42.0% | 22.0% | Turkmenistan |
| 2010s | 46.5% | 55.0% | 8.5% | Turkmenistan |
| 2020s | 94.3% | 100.0% | 5.7% | Turkmenistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Europe (WHO region) or Turkmenistan?
- Turkmenistan, at 100.0% against 90.0% in Europe (WHO region) as of 2022.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Europe (WHO region) and Turkmenistan?
- 10.0%, with Turkmenistan ahead.
- How many years of comparable data are there for Europe (WHO region) and Turkmenistan?
- 6 years are reported by both, from 2006 to 2022.
- How do Europe (WHO region) and Turkmenistan rank globally for previously treated cases tested for rr-/mdr-tb?
- Europe (WHO region) ranks 2nd and Turkmenistan ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.